• News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in glaxosmithkline

Unilever To Merge With GSK Consumer, Adds Iconic Horlicks Nutrition Business To Its Portfolio

The deal, announced today, marks a further step by drugmaker GSK to streamline its business and follows a competitive auction in which Unilever saw off rival Nestle, as well as earlier interest from Coca-Cola

Read More

GSK Consumer Healthcare Appoints Rahul Kapoor As EVP HR For India Sub- Continent

GSK Consumer Healthcare Ltd. appoints Rahul Kapoor as the EVP HR, ISC effective 1 June 2018

Read More

P&G To Buy German Merck's Consumer Health Unit For USD 4.2 Billion

The deal follows GlaxoSmithKline agreeing to buy Novartis out of their consumer healthcare joint venture for $13 billion after dropping its pursuit of Pfizer's consumer unit

Read More

GSK Buys Out Novartis In USD 13 Billion Consumer Healthcare Shake-Up

GSK's biggest move since Emma Walmsley became chief executive last year follows the British drugmaker's decision last week to quit the race to buy Pfizer's consumer healthcare business, endangering an auction the U.S. company hoped would bring in as much as $20 billion

Read More

GlaxoSmithKline Prescribes Commercial Reboot For Pharma Division

Miels - a long-time protege of AstraZeneca CEO Pascal Soriot, whose departure sparked a legal spat between the rival drugmakers - is a key lieutenant for Walmsley as she tries to overhaul the core pharma business

Read More

GlaxoSmithKline Names Insider Emma Walmsley As New CEO

Walmsley, 47, joined Britain's biggest drugmaker in 2010 from L’Oreal and will replace Andrew Witty, who had previously announced his decision to retire on March 31, 2017

Read More

GlaxoSmithKline And Alphabet Create $715 Million Bioelectronics Firm

Verily Life Sciences - known as Google's life sciences unit until last year - and Britain's biggest drugmaker will together contribute 540 million pounds over seven years to Galvani Bioelectronics

Read More

Amgen Reacquires Rights To Three Drugs From Glaxo In 48 Countries

Amgen expects to complete the transition in the majority of these emerging markets within a 12-month period. It expects the deal to add to its adjusted earnings beginning in 2017

Read More